Stocks/Funds/CIK 1596468

Almitas Capital LLC

Quarterly 13F filings · Latest period 2026-03-31 · CIK 1596468
Assets
$442M
+48.0% YoY
Holdings
114
Lifetime alpha vs market
+11.23% annual
Average hold time
1.4 yr
median 1.0 yr

Quarterly history

Cum return +133% vs S&P +52% · α +81% lifetimeAUM $442M · peak $454MFlow $-14M (-3%)2018-122020-032022-032023-032024-032025-032026-03
AUM ($B)fundS&P 500(gap = α)/ Flow in/out

Behavior signals (lifetime)

Dip response
+8.73%
adds when stocks drop
when a holding falls −10%+
Middle response
-10.86%
baseline attrition
Rally response
-17.76%
trims into rallies
when a holding rises +10%+

Top positions · 30

Ticker$ value% portYoYHold time
FBTCFidelity Wise Origin Bit$91M20.5%1.8 yr
BTTBlackrock Municipal 2030$34M7.6%2.5 yr
ASAASA Gold and Precious Me$33M7.4%+106.2%2.0 yr
AMLXAmylyx Pharmaceuticals, $30M6.7%+292.7%2.0 yr
DSGNDesign Therapeutics, Inc$16M3.7%+175.6%2.5 yr
NQPNuveen Pennsylvania Qual$13M2.9%3.5 yr
PDXPIMCO Dynamic Income Str$12M2.7%3.5 yr
LYELLyell Immunopharma, Inc.$12M2.6%1.0 yr
BIOBio-Rad Laboratories, In$8M1.9%+14.4%0.3 yr
CNNECannae Holdings, Inc.$8M1.9%-35.7%1.3 yr
CRFCornerstone Total Return$8M1.8%1.3 yr
BMEZBlackRock Health Science$7M1.6%2.3 yr
ALXOALX Oncology Holdings In$6M1.4%+222.6%1.5 yr
BRSPBrightSpire Capital, Inc$6M1.3%+10.0%3.5 yr
DSMBNY Mellon Strategic Mun$6M1.3%2.5 yr

Portfolio composition (YoY)

Industry mix
Asset Management34.5%+8.6pp$153M
Asset Management - Cryptocurrency20.5%-19.3pp$91M
Biotechnology16.9%+8.8pp$75M
Asset Management - Income10.5%-2.7pp$46M
Asset Management - Global2.5%+0.5pp$11M
Medical - Devices1.9%$8M
Restaurants1.9%+1.0pp$8M
Asset Management - Bonds1.7%-2.5pp$7M
REIT - Mortgage1.5%+0.8pp$6M
REIT - Diversified1.3%+0.4pp$6M
Country
US88.5%+6.0pp
GB7.6%-3.4pp
Unknown1.0%-1.0pp
JP1.0%-0.4pp
MX0.9%-0.8pp
DE0.7%-0.3pp
HK0.3%+0.2pp
Top 5: 45.9% · Top 10: 57.9% · Top 25: 76.2%

Winners

TickerPrev $PnLYoY %
AMLX$8M+0.02B292.7%
DSGN$6M+0.01B175.6%
ANTX$2M+0.00B151.5%
ALXO$1M+0.00B222.6%
BRSP$3M+0.00B10.0%

Losers

TickerPrev $PnLYoY %
CNNE$3M-0.00B-35.7%
CCAP$0M-0.00B-22.0%

Top buys this quarter · 15

ASA ASA Gold and Precious Metals L+$9M
BIO Bio-Rad Laboratories, Inc.new+$8M
CNNE Cannae Holdings, Inc.+$4M
TRTX TPG RE Finance Trust, Inc.new+$3M
RLYB Rallybio Corporationnew+$2M
BANX ArrowMark Financial Corp.new+$1M
FLGT Fulgent Genetics, Inc.+$1M
MRCC Monroe Capital Corporation+$5M
ALXO ALX Oncology Holdings Inc.+$1M
LADR Ladder Capital Corp+$1M

Top sells this quarter · 15

0HHU.L ARMOUR Residential REIT, Inc.exit$3M
GERN Geron Corporationexit$1M
CCAP Crescent Capital BDC, Inc.$1M
CABA Cabaletta Bio, Inc.$1M
BRSP BrightSpire Capital, Inc.$0M
HQL Tekla Life Sciences Investors$0M
GPMT Granite Point Mortgage Trust I$0M
DSGN Design Therapeutics, Inc.$14M
MUC BlackRock MuniHoldings Califor$0M
ECAT BlackRock ESG Capital Allocati$0M

Quarterly history (TTM returns)

PeriodAUM# PosReturn (1yr)SPY (1yr)Alpha (1yr)Flow
2026-03-31$442M114+96.66%+17.59%+79.07%-0.01B
2025-12-31$452M105+67.70%+17.72%+49.98%-0.03B
2025-09-30$435M64+51.87%+17.52%+34.35%-0.18B
2025-06-30$394M80+25.48%+14.94%+10.54%+0.06B
2025-03-31$299M79+0.66%+8.30%-7.64%-0.09B
2024-12-31$454M90+29.34%+24.89%+4.45%+0.17B
2024-09-30$281M67+42.82%+36.04%+6.78%-0.03B
2024-06-30$239M75+12.04%+24.49%-12.45%+0.04B
2024-03-31$217M67+36.60%+29.62%+6.97%-0.07B
2023-12-31$263M112+26.85%+26.18%+0.67%+0.06B
2023-09-30$183M84+28.26%+21.57%+6.69%-0.02B
2023-06-30$206M86+11.13%+19.42%-8.30%-0.02B
2023-03-31$201M93-13.87%-7.82%-6.05%+0.01B
2022-12-31$189M122+12.07%+7.56%+4.51%+0.06B
2022-09-30$114M81-12.59%-4.93%-7.67%-0.04B
2022-06-30$172M111-14.35%-16.11%+1.76%+0.05B